Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Data show cardiometabolic benefits of Type 2 diabetes treatment
Orphan Drug Designation for potential best-in-class ADC for sarcoma
FDA Breakthrough Therapy Designation for spinal muscular atrophy treatment
Servier acquiring Edgewise Therapeutics’ muscular dystrophy business
Antibody fragment prevents haemorrhages associated with new Alzheimer’s treatments
Fast Track Designation for Lynch syndrome-associated cancers treatment
Positive data from linear IgA disease study
Base to Base biotech podcast 62: A new approach to strokes